Inotiv Inc (NOTV)

NASDAQ
Currency in USD
2.190
+0.230(+11.73%)
Closed·
After Hours
2.200+0.010(+0.457%)
·
NOTV Scorecard
Full Analysis
Operates with a significant debt burden
NOTV is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.0502.210
52 wk Range
1.1506.480
Key Statistics
Edit
Prev. Close
2.19
Open
2.12
Day's Range
2.05-2.21
52 wk Range
1.15-6.48
Volume
476.12K
Average Vol. (3m)
753.02K
1-Year Change
-41.76%
Book Value / Share
4.66
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NOTV Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
5.167
Upside
+135.92%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

Inotiv Inc Company Profile

Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. It operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the company’s BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.

Inotiv Inc Earnings Call Summary for Q2/2025

  • Inotiv Inc reported Q2 FY2025 EPS of -$0.44, beating -$0.625 forecast; revenue grew 4.4% YoY to $124.3M, slightly below expectations
  • Stock surged 14.2% in regular trading and 1.49% after hours; company appears undervalued according to InvestingPro analysis
  • Adjusted EBITDA improved to $8.0M from $3.1M YoY; company expects continued revenue growth and reversal of discovery business decline
  • CEO emphasized adaptability and role in developing new methodologies aligned with FDA goals; Investor Day planned for May 29
  • Challenges include ongoing net losses, potential NIH funding impacts, DSA segment margin pressures, and regulatory changes
Last Updated: 05/07/2025, 05:34 PM
Read Full Transcript

Compare NOTV to Peers and Sector

Metrics to compare
NOTV
Peers
Sector
Relationship
P/E Ratio
−0.8x−5.8x−0.5x
PEG Ratio
0.070.130.00
Price / Book
0.5x1.6x2.6x
Price / LTM Sales
0.2x1.9x2.9x
Upside (Analyst Target)
141.0%68.9%53.0%
Fair Value Upside
Unlock10.4%8.9%Unlock

Analyst Ratings

2 Buy
1 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 5.167
(+135.92% Upside)

Earnings

Latest Release
May 07, 2025
EPS / Forecast
-0.44 / -0.63
Revenue / Forecast
124.32M / 125.13M
EPS Revisions
Last 90 days

People Also Watch

3.900
LDWY
+1.04%
3.32
CLAR
+2.79%
23.00
LIVE
+14.94%
3.310
SGMT
+1.53%
1.5100
PLAG
+22.76%

FAQ

What Is the Inotiv (NOTV) Stock Price Today?

The Inotiv stock price today is 2.19

What Stock Exchange Does Inotiv Trade On?

Inotiv is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Inotiv?

The stock symbol for Inotiv is "NOTV."

What Is the Inotiv Market Cap?

As of today, Inotiv market cap is 74.17M.

What Is Inotiv's Earnings Per Share (TTM)?

The Inotiv EPS (TTM) is -3.09.

When Is the Next Inotiv Earnings Date?

Inotiv will release its next earnings report on Aug 06, 2025.

From a Technical Analysis Perspective, Is NOTV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.